Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Chou, Che Yi ^a,b   Liang, Chih Chia ^a   Kuo, Huey Liang ^a,b   Chang, Chiz Tzung ^a,b   Liu, Jiung Hsiun ^a,b   Lin, Hsin Hung ^a,b   Wang, I Kuan ^a,b   Yang, Ya Fei ^a,b   Huang, Chiu Ching ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; NEW ONSET DIABETES MELLITUS; PERITONEAL DIALYSIS; REGISTER; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TAIWAN; COMPLICATION; INCIDENCE; PROPENSITY SCORE; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RISK;

ADULT; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PERITONEAL DIALYSIS; PROPENSITY SCORE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK;

EID: 84895171344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087891     Document Type: Article

References (40)

1. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, et al. (2003) Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 3: 590-598. (Pubitemid 36612842)
2. Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, et al. (2007) New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis. Am J Kidney Dis 49: 524-532. (Pubitemid 46441605)
3. Lin-Tan DT, Lin JL, Wang LH, Wang LM, Huang LM, et al. (2007) Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. J Am Soc Nephrol 18: 2385-2391.
4. Scantlebury V, Shapiro R, Fung J, Tzakis A, McCauley J, et al. (1991) New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 23: 3169-3170.
5. Giannarelli R, Coppelli A, Boggi U, Rizzo G, Barsotti M, et al. (2005) New-onset diabetes after kidney transplantation. Diabet Med 22: 1125-1126.
6. Hornum M, Jorgensen KA, Hansen JM, Nielsen FT, Christensen KB, et al. (2010) New-onset diabetes mellitus after kidney transplantation in Denmark. Clin J Am Soc Nephrol 5: 709-716.
7. Klein CL, Brennan DC (2010) The tradeoff between the risks of acute rejection and new-onset diabetes after kidney transplant. Am J Kidney Dis 56: 1026-1028.
8. Mari A, Tura A, Natali A, Laville M, Laakso M, et al. (2010) Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia 53: 749-756.
9. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46: 3-19.
10. DeFronzo RA (1981) Glucose intolerance and aging. Diabetes Care 4: 493-501.
11. Defronzo RA (1979) Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28: 1095-1101.
12. Poitout V, Robertson RP (2002) Minireview: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 143: 339-342. (Pubitemid 34107184)
13. Tien KJ, Lin ZZ, Chio CC, Wang JJ, Chu CC, et al. (2013) Epidemiology and Mortality of New-Onset Diabetes Mellitus After Dialysis: Taiwan national cohort study. Diabetes Care.
14. Verduijn M, Grootendorst DC, Dekker FW, Jager KJ, le Cessie S (2011) The analysis of competing events like cause-specific mortality-beware of the Kaplan-Meier method. Nephrol Dial Transplant 26: 56-61.
15. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM (2000) Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 35: 293-300. (Pubitemid 30070852)
16. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, et al. (2010) Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 21: 499-506.
17. Chou CY, Wang IK, Liu JH, Lin HH, Wang SM, et al. (2010) Comparing survival between peritoneal dialysis and hemodialysis treatment in ESRD patients with chronic hepatitis C infection. Perit Dial Int 30: 86-90.
18. Lin HH, Tsai CW, Lin PH, Cheng KF, Wu HD, et al. (2012) Survival analysis of pediatric dialysis patients in Taiwan. Nephrology (Carlton) 17: 621-627.
19. Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320: 479-482. (Pubitemid 30173118)
20. Luger A, Kovarik J, Stummvoll HK, Urbanska A, Luger TA (1987) Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32: 84-88. (Pubitemid 17094502)
21. Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schulze M, et al. (1996) Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit Dial Int 16: 158-162. (Pubitemid 26156401)
22. Nakahama H, Tanaka Y, Shirai D, Miyazaki M, Imai N, et al. (1992) Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients. Nephron 61: 132-134.
23. Porrini E, Gomez MD, Alvarez A, Cobo M, Gonzalez-Posada JM, et al. (2007) Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes. Nephrol Dial Transplant 22: 1994-1999. (Pubitemid 47244772)
24. Festa A, D'Agostino R, Jr., Tracy RP, Haffner SM, Insulin Resistance Atherosclerosis S (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51: 1131-1137. (Pubitemid 34438360)
25. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334. (Pubitemid 32656163)
26. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, et al. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51: 1596-1600. (Pubitemid 34826630)
27. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS, Jr. (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325: 147-152.
28. Bonnardeaux A, Pichette V, Ouimet D, Geadah D, Habel F, et al. (1992) Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Am J Kidney Dis 19: 31-38.
29. Ramirez G, Bercaw BL, Butcher DE, Mathis HL, Brueggemeyer C, et al. (1986) The role of glucose in hemodialysis: the effects of glucose-free dialysate. Am J Kidney Dis 7: 413-420. (Pubitemid 16019530)
30. Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, et al. (2007) Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med 167: 1853-1860. (Pubitemid 47481480)
31. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, et al. (2007) Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 30: 2453-2457. (Pubitemid 47547771)
32. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, et al. (2005) Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 28: 2864-2870. (Pubitemid 43942916)
33. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS (1999) Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22: 403-408. (Pubitemid 29106894)
34. Bjorntorp P (1993) Visceral obesity: a "civilization syndrome". Obes Res 1: 206-222.
35. Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud'Homme D, et al. (1992) Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41: 826-834.
36. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL (1999) Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48: 839-847. (Pubitemid 29153085)
37. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM (1995) Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96: 88-98.
38. Bayes B, Granada ML, Pastor MC, Lauzurica R, Salinas I, et al. (2007) Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am J Transplant 7: 416-422. (Pubitemid 46096335)
39. Lin CH, Chou CY, Lin CC, Huang CC, Liu CS, et al. (2007) Waist-to-height ratio is the best index of obesity in association with chronic kidney disease. Nutrition 23: 788-793. (Pubitemid 47532397)
40. Nilsson PM (2010) ACCORD and Risk-Factor Control in Type 2 Diabetes. N Engl J Med 362: 1628-1630.